Do MRI-negative relapses really exist? – No

Thompson AJ Banwell BL Barkhof F , et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17(2): 162–173.

Gavoille A Rollot F Casey R , et al. Acute clinical events identified as relapses with stable magnetic resonance imaging in multiple sclerosis. JAMA Neurol; 81(8): 814–823.

Alvarez E Bodhinathan K Xu Y , et al. MS relapse redefined: Addressing the radiological/pseudoexacerbation paradox with high efficacy therapy in the ULTIMATE I and II Trials. ACTRIMS, 2024.

Alvarez E Priest J Hennon S , et al. MRI-supported relapses as a potential relapsing multiple sclerosis (RMS) trial outcome measure: Use in the opera I and II trials with ocrelizumab. In: Poster presentation at the 2025 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC), May 2025, Phoenix, AZ.

Lublin FD Häring DA Ganjgahi H , et al. How patients with multiple sclerosis acquire disability. Brain 2022; 145(9): 3147–3161.

Müller J Cagol A Lorscheider J , et al. Harmonizing definitions for progression independent of relapse activity in multiple sclerosis: A systematic review. JAMA Neurol 2023; 80(11): 1232–1245.

Krieger SC Cook K De Nino S , et al. The topographical model of multiple sclerosis: A dynamic visualization of disease course. Neurol Neuroimmunol Neuroinflamm 2016; 3(5): e279.

Rocca MA Preziosa P Barkhof F , et al. Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis. Lancet Reg Health Eur 2024; 44: 100978.

Tallantyre EC Causon EG Harding KE , et al. The aetiology of acute neurological decline in multiple sclerosis: Experience from an open-access clinic. Mult Scler 2015; 21(1): 67–75.

Frohman TC Davis SL Beh S , et al. Uhthoff’s phenomena in MS–clinical features and pathophysiology. Nat Rev Neurol 2013; 9(9): 535–540.